Financials

News Discussions Technicals Seasonals

4599 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

StemRIM, Inc. engages in the research and development of regeneration inducing medicine. It deals with areas of disease and pipelines, autologous cell sampling devices for medical treatment, autologous stem cell collection, stem cell gene therapy and others. The company was founded by Katsuto Tamai on October 30, 2006 and is headquartered in Ibaraki, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

4599 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company